-
CRN urges FDA to reconsider provisions in New Dietary Ingredient Draft Guidance
WASHINGTON — The Food and Drug Administration's New Dietary Ingredient Draft Guidance should not give the agency pre-market approval over new dietary supplement products, the Council for Responsible Nutrition claimed Monday in a commentary published in Regulatory Toxicology and Pharmacology, the official journal of the International Society of Regulatory Toxicology and Pharmacology.
-
Cornell study weighs the cost of obesity
ITHACA, N.Y. — Obesity now accounts for almost 21% of U.S. healthcare costs — more than twice the previous estimates — according to a new Cornell University study released Monday.
The research, one of the first to show a causal effect of obesity on medical care costs, utilized new methods and makes a stronger case for government intervention to prevent obesity, the authors wrote in the January issue of the Journal of Health Economics.